このエントリーをはてなブックマークに追加
ID 52337
FullText URL
Author
Kitagawa, Masashi Kaken ID
Morinaga, Hiroshi
Inoue, Tatsuyuki
Takiue, Keiichi
Ogawa, Ayu
Yamanari, Toshio
Kikumoto, Yoko
Kitamura, Shinji Kaken ID publons
Nakamura, Kazufumi Kaken ID publons researchmap
Ito, Hiroshi Kaken ID
Abstract
Background: Klotho was originally identified in a mutant mouse strain unable to express the gene that consequently showed shortened life spans. In humans, low serum Klotho levels are related to the prevalence of cardiovascular diseases in community-dwelling adults. However, it is unclear whether the serum Klotho levels are associated with signs of vascular dysfunction such as arterial stiffness, a major determinant of prognosis, in human subjects with chronic kidney disease (CKD). Methods: We determined the levels of serum soluble Klotho in 114 patients with CKD using ELISA and investigated the relationship between the level of Klotho and markers of CKD-mineral and bone disorder (CKD-MBD) and various types of vascular dysfunction, including flow-mediated dilatation, a marker of endothelial dysfunction, ankle-brachial pulse wave velocity (baPWV), a marker of arterial stiffness, intima-media thickness (IMT), a marker of atherosclerosis, and the aortic calcification index (ACI), a marker of vascular calcification. Results: The serum Klotho level significantly correlated with the 1,25-dihydroxyvitamin D level and inversely correlated with the parathyroid hormone level and the fractional excretion of phosphate. There were significant decreases in serum Klotho in patients with arterial stiffness defined as baPWV >= 1400 cm/sec, atherosclerosis defined as maximum IMT >= 1.1 mm and vascular calcification scores of ACI>0%. The serum Klotho level was a significant determinant of arterial stiffness, but not endothelial dysfunction, atherosclerosis or vascular calcification, in the multivariate analysis in either metabolic model, the CKD model or the CKD-MBD model. The adjusted odds ratio of serum Klotho for the baPWV was 0.60 (p = 0.0075). Conclusions: Decreases in the serum soluble Klotho levels are independently associated with signs of vascular dysfunction such as arterial stiffness in patients with CKD. Further research exploring whether therapeutic approaches to maintain or elevate the Klotho level could improve arterial stiffness in CKD patients is warranted.
Published Date
2013-02-19
Publication Title
PLoS ONE
Volume
volume8
Issue
issue2
Publisher
Public Library Science
ISSN
1932-6203
Content Type
Journal Article
Related Url
http://ousar.lib.okayama-u.ac.jp/metadata/52241
language
English
Copyright Holders
© 2013 Kitagawa et al.
File Version
publisher
Refereed
True
DOI
Web of Science KeyUT